Rehabkompassen® - a Patient-centered Digital Follow-up Tool in the Post-stroke Continuum of Care

Summary

Stroke is a leading cause of disability and with a heavy burden for the society. Despite the demands from 'Socialstyrelsen' of improving post-acute care, an effective structured follow-up to promote a patient-tailored rehabilitation remains largely lacking in the current stroke care.

The overall aim of this study is to find a cost-effective solution to facilitate patient-tailored rehabilitation that improves daily and social activities and health-related quality of life for persons discharged from the acute care after stroke. We have recently developed a novel digital graphic tool, Rehabkompassen®, which based on patient-reported outcome measurements captures the patient's complex health status after stroke.

Here, this tool will be used in a parallel, open-label, 2-arm prospective and multicenter pragmatic randomized controlled trial between 2022-2026. All participants (n = 1106) will be randomized according to permuted block design; and receive a usual care without (control group, n = 553) or with (intervention group, n = 553) Rehabkompassen®, within 3-month after stroke. The effectiveness of the tool on daily and social activities, quality of life and its health-economic effects will be compared at 12-month follow-up post stroke.

We hypothesize that the digital tool Rehabkompassen® will provide a patient-tailored rehabilitation that improves recovery, independence, and quality of life among people with stroke in a cost-effective way.

Conditions

• Stroke

Interventions

OTHER

a usual follow-up with Rehabkompassen®

Rehabkompassen® is a patient-centered digital graphic tool for capturing the patient's rehabilitation needs in the follow-up after stroke.

OTHER

a usual follow-up with Post-Stroke Checklist, i.e. without Rehabkompassen®

Post-Stroke Checklist consists of eleven questions concerning common and treatable post-stroke problems affecting quality of life.

Sponsors & Collaborators

• The Swedish Research Council

  collaborator OTHER_GOV

• Forte: Swedish research council for health, working life and welfare

  collaborator UNKNOWN

• Swedish Heart Lung Foundation

  collaborator OTHER

• Vinnova

  collaborator OTHER_GOV

• Strokeförbundet

  collaborator UNKNOWN

• Västerbotten County Council, Sweden

  collaborator OTHER_GOV

• Göteborg University

  collaborator OTHER

• Vastra Gotaland Region

  collaborator OTHER_GOV

• Uppsala University

  collaborator OTHER

• Uppsala County Council, Sweden

  collaborator OTHER_GOV

• Karolinska Institutet

  collaborator OTHER

• Region Stockholm

  collaborator OTHER_GOV

• Västmanland County Council, Sweden

  collaborator OTHER_GOV

• Värmland County Council, Sweden

  collaborator OTHER_GOV

• Sormland County Council, Sweden

  collaborator OTHER

• Region Skane

  collaborator OTHER

• Umeå University

  lead OTHER

Principal Investigators

• Xiaolei Hu, MD PhD · Umeå University

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2020-08-26

Primary Completion

2027-12-31

Completion

2027-12-31

Countries

• Sweden

Study Locations